Sacituzumab govitecan Interactions
There are 231 drugs known to interact with sacituzumab govitecan, along with 2 disease interactions. Of the total drug interactions, 80 are major, 136 are moderate, and 15 are minor.
- View all 231 medications that may interact with sacituzumab govitecan
- View sacituzumab govitecan disease interactions (2)
Most frequently checked interactions
View interaction reports for sacituzumab govitecan and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Benadryl (diphenhydramine)
- Centrum Adults (multivitamin with minerals)
- Claritin (loratadine)
- Cymbalta (duloxetine)
- FeroSul (ferrous sulfate)
- Imodium (loperamide)
- Lyrica (pregabalin)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Movantik (naloxegol)
- Myrbetriq (mirabegron)
- Pepto-Bismol (bismuth subsalicylate)
- Plaquenil (hydroxychloroquine)
- Rx Triamcinolone (triamcinolone topical)
- Slow-K (potassium chloride)
- Taxol (paclitaxel)
- Tylenol (acetaminophen)
- Ventolin HFA (albuterol)
- Verzenio (abemaciclib)
- Vitamin B12 (cyanocobalamin)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Sacituzumab govitecan disease interactions
There are 2 disease interactions with sacituzumab govitecan which include:
Report options
QR code containing a link to this page
More about sacituzumab govitecan
- sacituzumab govitecan consumer information
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
